SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-20-019258
Filing Date
2020-06-09
Accepted
2020-06-09 18:07:00
Documents
1
Period of Report
2020-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 2743
  Complete submission text file 0001127602-20-019258.txt   4085
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address APELLIS PHARMACEUTICALS, INC. 100 5TH AVENUE, 3RD FLOOR WALTHAM MA 02451
Business Address
Lewis Karen (Reporting) CIK: 0001814304 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38276 | Film No.: 20953015